The field of the invention relates to nuclear medicine and more particularly, to methods of processing radioactive nuclides.
The use of radioactive materials in nuclear medicine for therapeutic and diagnostic purposes is known. In the case of diagnostic medicine, radioactive material may be used to track blood flow for purposes of detecting obstructions or the like. In this case the radioactive material (e.g., a tracer) may be injected into a vein of the arm or leg of a person.
A scintillation camera may be used to collect images of the person following the injection. In this case, the gamma rays of the tracer interact with a detector of the camera to create images of the person.
A series of images are collected as the tracer perfuses through the person. Since the tracer diffuses through the blood of the person, the veins or arteries with greater blood flow produce a greater signature from the tracer.
Alternatively, radioactive material may be coupled at a molecular level with a biolocalization agent. In this case, the biolocalization agent may concentrate the radioactive material at some specific location (e.g., the site of a tumor).
Key to the use of radioactive materials in nuclear medicine is the creation of nuclear materials with a relatively short half life (e.g., 2-72 hours). In the case of the use of the radioactive materials with a biolocalization agent or for imaging, the short half life causes the radioactivity to decay rapidly in such as way as to reduce exposure of the person to radiation.
While the use of radioactive materials in nuclear medicine is extremely useful, the handling of such materials can be difficult. Materials with short half lives may require complex separation procedures to isolate the desired material from other materials. Once separated, the desired material must be easily accessible for injection into the patient. Accordingly, a need exists for better methods of handling such materials.
The system 10 may be used to separate a parent radionuclide from a daughter radionuclide using a forward COW process and where the daughter radionuclide is produced by the decay of the parent radionuclide. The system 10 may also be used to separate a daughter radionuclide from a parent radionuclide using a reverse COW process.
Included within the system 10 may be one or more separation columns 28, 36. The separation column 28 may be selected for purification of a wide range of radionuclides depending upon the diagnostic or therapeutic objectives. For example, the separation columns 26, 36 may be filled within a chromatographic material (e.g., ion-exchange resin, extraction chomotographic material, etc.) targeted for the specific radionuclide needed. In this regard, the system 10 may be used for the purification of yttrium-90, bismuth-212 and 213, or rhenium-188 for radiotherapy or technetium-99 m, thallium-201, fluorine-18 or indium-111 for diagnostic imaging.
In this regard, the system 10 may be provided with a parent radionuclide. After some period of time, some of the parent radionuclide will decay to produce a mixture of parent and daughter radionuclides. In this case, a controller 34 of the system 10 may activate one or more valves 22, 24, 26 and a pump 30 to transport the mixture of the parent and daughter radionuclides from a parent radionuclide container 12 to a first separation column 28 that captures the daughter radionuclide. Once the mixture of parent and daughter radionuclides has passed through the separation column 28, the remaining parent may be transported back to the parent container 12.
The controller 34 may wash the first separation column 28 by activating valves 22, 24 to first withdraw a wash solution from a processing fluids container 14, 16 and then to discard the wash solution into a waste container 18, 20. The wash process may be repeated any of a number of times with the same or different types of wash solutions.
Once washed, the controller 34 may withdraw a stripping solution from one of the processing fluids containers 14, 16 and then pump the stripping solution through the first separation column 28, through valve 26 and into the product cartridge assembly 32. The stripping solution functions to release the daughter radionuclide from the separator column 28 and then transport the daughter radionuclide into the product cartridge assembly 32.
To withdraw the parent radionuclide from the case, the sterile tube is removed from its protective package and the plug is removed from the second aperture of the stopper. The sterile tube is then inserted through the second aperture and the fill tube into the storage bottle. The parent radionuclide may then be removed from the storage bottle and case through the sterile tube.
As shown in
As shown in
Similarly, the stopper 58 is arranged at an angle that is offset from the vial 56. Offset in this context means that a line passing down through the central bore or channel of the stopper 58 would not pass through any part of the vial 56. In this way radiation cannot propagate in a straight line from the vial 56 and through the central bore of the stopper 58 to irradiate a person handling the container 12.
The first tube 62 is also curved as it extends from the vial 56 to the stopper 58. In this way radiation cannot propagate in a straight line from the vial 56 up the first tube 62 and through the stopper 58. The curve in the first tube 62 further operates to reduce radiation leakage.
The container of
A plug 108 is inserted into the aperture. A removable cap 106 prevents accidental removal of the plug. The removable cap may have an aperture covered by a filter that allows the pressure inside the vial to equalize with atmospheric pressure
The first tube 112 allows a second, slightly smaller tube to be inserted through the first tube and into the vial. The second, slightly smaller may be connected with the tube 60 of
In general, providing the container includes providing a radiation impervious case, disposing a vial that holds a parent radionuclide within the case, venting the vial along a curved path between the vial and a stopper that is external to the case and connecting a fill tube between the vial and external stopper, said fill tube at least partially following the curved path of the vent.
The system includes a container suited for a parent radionuclide, the container further includes a radiation impervious case, a vial disposed within the radiation impervious case that holds the parent radionuclide within the case, a passageway extending along a curved path between the vial and a stopper that is external to the case and a fill tube that extends along the passageway between the vial and external stopper, said fill tube at least partially following the curved path of the vent.
A specific embodiment of method and apparatus for generating radionuclides has been described for the purpose of illustrating the manner in which the invention is made and used. It should be understood that the implementation of other variations and modifications of the invention and its various aspects will be apparent to one skilled in the art, and that the invention is not limited by the specific embodiments described. Therefore, it is contemplated to cover the present invention and any and all modifications, variations, or equivalents that fall within the true spirit and scope of the basic underlying principles disclosed and claimed herein.
This Application is a continuation-in-part of U.S. Provisional Patent Application No. 61/897,489 filed on Oct. 30, 2013.
Number | Name | Date | Kind |
---|---|---|---|
3120613 | Prest | Feb 1964 | A |
3673411 | Glasser | Jun 1972 | A |
4020355 | Czaplinski | Apr 1977 | A |
4241728 | Mirell | Dec 1980 | A |
4560069 | Simon | Dec 1985 | A |
4880119 | Simon | Nov 1989 | A |
7199375 | Drobnik | Apr 2007 | B2 |
20130053815 | Mucientes | Feb 2013 | A1 |
Number | Date | Country | |
---|---|---|---|
20150179289 A1 | Jun 2015 | US |
Number | Date | Country | |
---|---|---|---|
61897489 | Oct 2013 | US |